|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
JST134575679 |
003 |
DE-627 |
005 |
20240125161849.0 |
007 |
cr uuu---uuuuu |
008 |
230311s2017 xx |||||o 00| ||eng c |
035 |
|
|
|a (DE-627)JST134575679
|
035 |
|
|
|a (JST)26364724
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Chen, Zhe
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset
|
264 |
|
1 |
|c 2017
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
520 |
|
|
|a Middle East respiratory syndrome coronavirus (MERS-CoV) infection in humans is highly lethal, with a fatality rate of 35%. New prophylactic and therapeutic strategies to combat human infections are urgently needed. We isolated a fully human neutralizing antibody, MCA1, from a human survivor. The antibody recognizes the receptor-binding domain of MERS-CoV S glycoprotein and interferes with the interaction between viral S and the human cellular receptor human dipeptidyl peptidase 4 (DPP4). To our knowledge, this study is the first to report a human neutralizing monoclonal antibody that completely inhibits MERS-CoV replication in common marmosets. Monotherapy with MCA1 represents a potential alternative treatment for human infections with MERS-CoV worthy of evaluation in clinical settings.
|
540 |
|
|
|a Copyright © 2016 Oxford University Press on behalf of the Infectious Diseases Society of America
|
655 |
|
4 |
|a research-article
|
700 |
1 |
|
|a Bao, Linlin
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chen, Cong
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zou, Tingting
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Xue, Ying
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Li, Fengdi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lv, Qi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Gu, Songzhi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Gao, Xiaopan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cui, Sheng
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Jianmin
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Qin, Chuan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Jin, Qi
|e verfasserin
|4 aut
|
773 |
1 |
8 |
|g volume:215
|g year:2017
|g number:12
|g pages:1807-1815
|
856 |
4 |
0 |
|u https://www.jstor.org/stable/26364724
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a GBV_JST
|
951 |
|
|
|a AR
|
952 |
|
|
|d 215
|j 2017
|e 12
|h 1807-1815
|